To amend the Public Health Services Act, commonly referred to as the "Clinical Laboratory Improvement Amendments" or "CLIA", with respect to laboratory developed tests, and for other purposes.

Neal P. Dunn

Republican · FL · Representative

Source: Congress.gov · FEC

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2026-05-19

Source: Congress.gov

The proposal would change how the federal government oversees laboratory tests that are developed and used by individual medical labs rather than mass-produced by companies. Currently, these "lab-developed tests" face minimal federal oversight, but this bill would require them to meet stricter safety and accuracy standards similar to commercial tests. The changes would affect hospitals, diagnostic labs, and patients who rely on these tests for medical decisions.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

• HR8500Timely Access to Coverage Decisions Act of 2026
  Referred to Committee · 2026-04-27
• HR7386First Responder Network Authority Reauthorization Act of 2026
  Passed House · 2026-04-21
• HR8032FAIC Act
  Referred to Committee · 2026-03-20
• HR1566REPAIR Act
  Referred to Committee · 2026-02-10